Mark J Alles's Net Worth

$28.5 Million

Estimate Recalculated Nov 5, 2024 07:09PM EST

Who is Mark J Alles

Mark J Alles has an estimated net worth of $28.5 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., BIOMARIN PHARMACEUTICAL INC, Syros Pharmaceuticals, Inc., and CELGENE CORP /DE/.

SEC CIK

Mark J Alles's CIK is 0001538897

Past Insider Trading and Trends

2015 was Mark J Alles's most active year for acquiring shares with 44 total transactions. Mark J Alles's most active month to acquire stocks was the month of January. 2015 was Mark J Alles's most active year for disposing of shares, totalling 42 transactions. Mark J Alles's most active month to dispose stocks was the month of January. 2013 saw Mark J Alles paying a total of $6,330,262.96 for 199,471 shares, this is the most they've acquired in one year. In 2013 Mark J Alles cashed out on 244,966 shares for a total of $16,397,873.10, their largest year based on trade value.

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Turning Point Therapeutics, Inc.

Investor

Updated Aug 17, 2022


Form 4	-100.00%	-19.21K	$76.00	-$152.00K	Aug 17, 2022	—	Disposition	—	Aug 17
Form 4	—	2.00K	$81.34	$162.68K	Jun 21, 2021	2.00K	Purchase	—	Jun 21
Form 4	—	209.00	—	—	Jun 04, 2021	209.00	Grant	—	Jun 02
Form 4	—	17.00K	—	—	May 26, 2021	17.00K	Grant	—	May 24
Form 3	—	—	—	—	May 26, 2021	—	—	—	—

Showing 5 results

BIOMARIN PHARMACEUTICAL INC

Investor

Updated May 24, 2023

View Quote Details


Form 4	38.42%	4.19K	—	—	May 24, 2023	15.10K	Grant	—	May 23
Form 4	49.79%	3.63K	$86.75	$314.47K	Nov 02, 2022	10.91K	Purchase	—	Oct 31
Form 4	216.52%	4.98K	—	—	May 26, 2022	7.28K	Grant	—	May 24
Form 4	—	2.30K	—	—	Jan 05, 2022	2.30K	Grant	—	Jan 03
Form 3	—	—	—	—	Jan 05, 2022	—	—	—	—

Showing 5 results

Syros Pharmaceuticals, Inc.

Investor

Updated Sep 19, 2023

View Quote Details


Form 4	—	—	—	—	Sep 19, 2023	9.00K	Options	—	Sep 16
Form 4	—	10.00K	—	—	Jun 02, 2023	10.00K	Grant	—	Jun 01
Form 4	—	20.00K	—	—	Sep 19, 2022	20.00K	Grant	—	Sep 16
Form 4	—	17.50K	—	—	Jun 02, 2022	17.50K	Grant	—	Jun 01
Form 4	—	17.50K	—	—	Jun 10, 2021	17.50K	Grant	—	Jun 08
Form 4	—	17.50K	—	—	Jun 11, 2020	17.50K	Grant	—	Jun 11
Form 4	—	10.00K	$8.86	$88.59K	May 13, 2020	10.00K	Purchase	—	May 13
Form 4	—	35.00K	—	—	Dec 20, 2019	35.00K	Grant	—	Dec 19
Form 3	—	—	—	—	Dec 20, 2019	—	—	—	—

Showing 9 results

CELGENE CORP /DE/

CEO, CHAIRMAN OF BOARD

Updated Nov 22, 2019


Form 4	-100.00%	-534.33K	—	—	Nov 22, 2019	—	Disposition	—	Nov 20
Form 4	-100.00%	-554.33K	—	—	Nov 22, 2019	—	Disposition	—	Nov 20
Form 4	-2.90%	-6.62K	$95.21	-$630.29K	May 06, 2019	227.52K	Options	—	May 02
Form 4	45.03%	101.86K	$85.96	-$1.19M	Mar 05, 2019	334.09K	Options	—	Mar 01
Form 4	—	18.80K	—	—	Feb 06, 2019	18.80K	Grant	—	Feb 04
Form 4	—	33.81K	—	—	Jan 30, 2019	33.81K	Grant	—	Jan 28
Form 4	-1.98%	-3.88K	$68.20	-$264.34K	Dec 18, 2018	198.43K	Options	—	Dec 16
Form 4	—	59.23K	—	—	Oct 31, 2018	59.23K	Grant	—	Oct 29
Form 4	—	59.23K	—	—	Aug 01, 2018	59.23K	Grant	—	Jul 30
Form 4	48.64%	90.52K	$82.60	$99.78K	May 17, 2018	282.69K	Purchase	—	May 08 - May 09
Form 4	-0.81%	-1.52K	$86.89	-$131.99K	May 08, 2018	192.16K	Options	—	May 04
Form 4	-1.11%	-2.06K	$95.26	-$196.24K	Feb 20, 2018	190.05K	Options	—	Feb 17
Form 4	—	7.28K	—	—	Feb 15, 2018	7.28K	Grant	—	Feb 13
Form 4	1.86%	3.26K	$91.90	$299.59K	Feb 08, 2018	184.83K	Purchase	—	Feb 08
Form 4	—	33.88K	—	—	Jan 31, 2018	33.88K	Grant	—	Jan 29
Form 4	-1.18%	-2.09K	$107.06	-$224.18K	Dec 20, 2017	181.57K	Options	—	Dec 19
Form 4	—	33.88K	—	—	Oct 31, 2017	33.88K	Grant	—	Oct 30
Form 4	18.24%	31.95K	$134.10	-$259.08K	Aug 01, 2017	212.99K	Options	—	Jul 28 - Jul 31
Form 4	—	51.01K	—	—	May 02, 2017	51.01K	Grant	—	May 01
Form 4	4.78%	7.80K	$117.02	-$777.36K	Feb 16, 2017	176.69K	Grant	—	Feb 14
Form 4	—	29.67K	—	—	Jan 31, 2017	29.67K	Grant	—	Jan 30
Form 4	-1.82%	-3.02K	$117.63	-$355.01K	Dec 06, 2016	168.89K	Options	—	Dec 02
Form 4	—	29.67K	—	—	Nov 02, 2016	29.67K	Grant	—	Oct 31
Form 4	—	29.67K	—	—	Aug 01, 2016	29.67K	Grant	—	Aug 01
Form 4	24.43%	40.22K	$103.41	-$523.46K	May 03, 2016	210.63K	Options	—	Apr 29 - May 02
Form 4	9.99%	13.95K	$102.45	-$1.22M	Feb 16, 2016	159.28K	Grant	—	Feb 12
Form 4	6.06%	8.63K	$27.51	$603.59K	Feb 02, 2016	156.65K	Options	—	Jan 29 - Feb 01
Form 4	2.64%	3.56K	$112.17	-$602.35K	Dec 18, 2015	143.99K	Options	—	Dec 16 - Dec 17
Form 4	—	8.63K	—	—	Nov 10, 2015	8.63K	Grant	—	Nov 09
Form 4	—	8.63K	—	—	Jul 29, 2015	8.63K	Grant	—	Jul 27
Form 4	5.98%	6.97K	$108.06	-$556.94K	May 04, 2015	129.21K	Options	—	Apr 30 - May 04
Form 4	-3.72%	-4.08K	$121.53	-$495.60K	Mar 03, 2015	111.04K	Options	—	Mar 01
Form 4	—	—	$45.43	$1.25M	Feb 17, 2015	234.35K	Options	—	Feb 12
Form 4	-30.50%	-100.36K	$81.12	-$11.25M	Feb 10, 2015	234.18K	Sale	Scheduled	Feb 06
Form 4	—	10.18K	—	—	Feb 04, 2015	10.18K	Grant	—	Feb 02
Form 4	—	20.22K	—	—	Dec 23, 2014	20.22K	Grant	—	Dec 19
Form 4	—	10.18K	—	—	Oct 29, 2014	10.18K	Grant	—	Oct 27
Form 4	—	24.55K	—	—	Jul 29, 2014	24.55K	Grant	—	Jul 28
Form 4	33.78%	8.35K	$160.54	-$1.10M	Feb 14, 2014	35.69K	Grant	—	Feb 12
Form 4	—	11.82K	—	—	Feb 05, 2014	11.83K	Grant	—	Feb 03
Form 4	-12.41%	-3.50K	$168.93	-$591.42K	Dec 31, 2013	27.33K	Options	—	Dec 27
Form 4	—	16.41K	—	—	Dec 04, 2013	16.41K	Grant	—	Dec 02
Form 4	-18.05%	-4.50K	$151.31	-$681.18K	Nov 05, 2013	23.06K	Options	—	Nov 01
Form 4	—	11.82K	—	—	Oct 28, 2013	11.83K	Grant	—	Oct 28
Form 4	-64.15%	-101.41K	$101.90	-$8.57M	Aug 02, 2013	59.29K	Sale	—	Jul 31 - Aug 02
Form 4	—	11.82K	—	—	Jul 31, 2013	11.83K	Grant	—	Jul 29
Form 4	—	17.32K	—	—	May 01, 2013	17.33K	Grant	—	Apr 29
Form 4	-26.58%	-1.79K	$123.00	-$220.29K	Apr 16, 2013	7.56K	Options	—	Apr 13
Form 4	—	8.32K	—	—	Jan 30, 2013	8.33K	Grant	—	Jan 28
Form 4	—	23.34K	—	—	Dec 19, 2012	23.34K	Grant	—	Dec 17
Form 4	—	8.32K	—	—	Nov 02, 2012	8.33K	Grant	—	Oct 31
Form 4	—	8.32K	—	—	Aug 01, 2012	8.33K	Grant	—	Jul 30
Form 4	—	13.93K	—	—	May 01, 2012	13.93K	Grant	—	Apr 30
Form 4	-29.52%	-902.00	$78.32	-$70.64K	Apr 17, 2012	4.56K	Options	—	Apr 14
Form 4	—	16.67K	—	—	Mar 07, 2012	16.67K	Grant	—	Mar 01
Form 3	—	—	—	—	Feb 24, 2012	2.41K	—	—	—

Showing 56 results